Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution
2014
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
2006 StandoutNobel
Global patterns and trends in colorectal cancer incidence and mortality
2016 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Microsatellite instability in colorectal cancer—the stable evidence
2010
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications
2006
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
2005 StandoutNature
Microsatellite Instability in Colorectal Cancer
2010 Standout
Liver fibrosis
2005 Standout
Mismatch repair and DNA damage signalling
2004
A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France
2012
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Steatosis: Co-factor in Other Liver Diseases *
2005
Molecular mechanisms of drug resistance
2005
Liver fibrosis – from bench to bedside
2003 Standout
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
2010
Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines
2003
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
2008
Direct Visualization of Asymmetric Adenine Nucleotide-Induced Conformational Changes in MutLα
2008 StandoutNobel
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
2005
Role of microsatellite instability in the management of colorectal cancers
2012
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
2011
Hydrolytic function of Exo1 in mammalian mismatch repair
2014 StandoutNobel
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Endonucleolytic Function of MutLα in Human Mismatch Repair
2006 StandoutNobel
Colorectal cancer
2013 Standout
Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
2004
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
2009
Colorectal cancer
2019 Standout
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Laparoscopicvsopen approach to resection of hepatocellular carcinoma in patients with known cirrhosis: Systematic review and meta-analysis
2014
Non-alcoholic fatty liver disease
2021 Standout
Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines
2002
Mismatch repair and response to DNA-damaging antitumour therapies
2003
Mechanisms of Hepatic Fibrogenesis
2008 Standout
DNA mismatch repair defects: role in colorectal carcinogenesis
2002
Is obesity a risk factor for cirrhosis-related death or hospitalization? a population-based cohort study
2003
Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies
2010
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
2004
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features
2007
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Milestones of Lynch syndrome: 1895–2015
2015
Role of DNA mismatch repair in apoptotic responses to therapeutic agents
2004
Global burden of liver disease: 2023 update
2023 Standout
MutLα and Proliferating Cell Nuclear Antigen Share Binding Sites on MutSβ
2010 StandoutNobel
Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
2008
Targeting DNA repair mechanisms in cancer
2012
Self-eating and self-killing: crosstalk between autophagy and apoptosis
2007 Standout
Advances in alcoholic liver disease
2003
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Expression of activation‐induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis
2006
Medical treatments for hepatocellular carcinoma (HCC): what’s next?
2006
Global challenges in liver disease
2006
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
2009
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis
2011
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Molecular Testing in Colorectal Cancer
2012
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
2009
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Microsatellite Instability and Colorectal Cancer Prognosis
2005
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells
2004
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
DNA Mismatch Repair Initiates 6-Thioguanine–Induced Autophagy through p53 Activation in Human Tumor Cells
2007
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Management of hepatocellular carcinoma: an overview of major findings from meta-analyses
2016
Works of David Fallik being referenced
Risk factors of fibrosis in alcohol-induced liver disease
2002
Meta‐analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma
2003
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
2006
Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
2003
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
2001
[Response of metastatic colorectal cancers to treatment with CPT11 (irinotecan): implications of the mismatched base repair system].
2000